Department of Public Health, Ege University Medical School, Izmir, Turkey.
BMC Public Health. 2010 Feb 17;10:71. doi: 10.1186/1471-2458-10-71.
According to the surveillance system in Turkey, most diseases are notified only by clinicians, without involving laboratory notification. It is assumed that a considerable inadequacy in notifications exists; however, this has not been quantified by any researcher. Our aim was to evaluate the completeness of communicable disease surveillance in the province of Izmir, Turkey for the year of 2003 by means of estimating the incidences of diseases.
Data on positive laboratory results for the notifiable and serologically detectable diseases hepatitis A, B, C, brucellosis, syphilis, measles and HIV detected in 2003 in Izmir (population 3.5 million) were collected from serology laboratories according to WHO surveillance standards and compared to the notifications received by the Provincial Health Directorate. Data were checked for duplicates and matched. Incidences were estimated with the capture-recapture method. Sensitivities of both notifications and laboratory data were calculated according to these estimates.
Among laboratories performing serologic tests (n = 158) in Izmir, 84.2% accepted to participate, from which 23,515 positive results were collected. Following the elimination of duplicate results as well as of cases residing outside of Izmir, the total number was 11,402. The total number of notifications was 1802. Notification rates of cases found in laboratories were 31.6% for hepatitis A, 12.1% for acute hepatitis B, 31.8% for brucellosis, 25.9% for syphilis and 100% for HIV confirmation.
It was discovered that for hepatitis A, B, C, brucellosis and syphilis, there is a considerable under-notification by clinicians and that laboratory data has the potential of contributing greatly to their surveillance. The inclusion of laboratories in the surveillance system of these diseases could help to achieve completeness of reporting.
根据土耳其的监测系统,大多数疾病仅由临床医生报告,而没有实验室报告。据推测,报告中存在相当大的不足,但尚未有研究人员对此进行量化。我们的目的是通过估计疾病的发病率,来评估 2003 年土耳其伊兹密尔省传染病监测的完整性。
根据世界卫生组织的监测标准,从血清学实验室收集了 2003 年伊兹密尔(人口 350 万)可报告和血清学可检测疾病(甲型肝炎、乙型肝炎、丙型肝炎、布鲁氏菌病、梅毒、麻疹和艾滋病)的阳性实验室结果数据,并与省卫生署收到的通知进行了比较。对数据进行了重复项检查和匹配。采用捕获-再捕获法估计发病率。根据这些估计,计算了通知和实验室数据的灵敏度。
在伊兹密尔进行血清学检测的实验室中(n=158),有 84.2%接受了参与,从中收集了 23515 份阳性结果。在消除重复结果以及居住在伊兹密尔以外的病例后,总数为 11402 例。总报告病例数为 1802 例。在实验室发现的病例中,肝炎 A 的报告率为 31.6%,急性乙型肝炎为 12.1%,布鲁氏菌病为 31.8%,梅毒为 25.9%,艾滋病确认为 100%。
研究发现,对于甲型肝炎、乙型肝炎、丙型肝炎、布鲁氏菌病和梅毒,临床医生的报告存在相当大的不足,实验室数据有可能对其监测做出重大贡献。将实验室纳入这些疾病的监测系统有助于实现报告的完整性。